Related Experiment Video
Updated: Nov 18, 2025
05:21
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
25.7K
Introductory paper: High-dose influenza vaccine.
Mia Diaco1, Lee-Jah Chang1, Bruce Seet2
1Sanofi Pasteur, Swiftwater, PA, USA.
Vaccine
|February 7, 2021
Summary
High-dose influenza vaccines offer improved prevention for older adults. This research reviews evidence supporting their benefits over ten seasons for healthy aging.
Area of Science:
- Gerontology
- Immunology
- Vaccinology
Background:
- Seasonal influenza poses a significant global health risk, particularly to adults aged 65 and older.
- The development of high-dose influenza vaccines marks a significant advancement in preventing influenza in this vulnerable population.
Discussion:
- This paper examines the evolution of high-dose influenza vaccines and the supporting scientific evidence.
- It introduces supplementary articles detailing the benefits of high-dose vaccines over a decade of use.
Key Insights:
- High-dose influenza vaccines demonstrate enhanced efficacy in preventing seasonal influenza among older adults.
- The evidence supports high-dose vaccines as a crucial tool for promoting healthy aging and reducing influenza-related morbidity.
Outlook:
- Continued research and application of high-dose influenza vaccines are essential for public health strategies.
- These vaccines represent a key component in the ongoing effort to mitigate the impact of influenza in aging populations.
